Price
$38.87
Increased by +0.57%
Dollar volume (20D)
35.76 M
ADR%
4.07
Earnings report date
Nov 5, 2025
Shares float
71.60 M
Shares short
6.89 M [9.63%]
Shares outstanding
77.11 M
Market cap
2.98 B
Beta
1.17
Price/earnings
N/A
20D range
30.00 39.58
50D range
30.00 39.58
200D range
26.74 46.00

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression.

The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy.

Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Reported date EPSChange YoY EstimateSurprise
Aug 11, 25 1.07
Increased by +242.67%
-0.99
Increased by +208.08%
Jun 4, 25 -0.83
Decreased by -33.87%
-0.90
Increased by +7.49%
Feb 26, 25 -0.84
Decreased by -31.25%
-0.84
Decreased by -0.10%
Nov 6, 24 -0.81
Decreased by -10.96%
-0.81
Aug 8, 24 -0.75
Decreased by -4.17%
-0.70
Decreased by -7.14%
May 9, 24 -0.62
Increased by +1.59%
-0.66
Increased by +6.06%
Feb 29, 24 -0.64
Decreased by -12.28%
-0.76
Increased by +15.79%
Nov 8, 23 -0.73
Decreased by -28.07%
-0.77
Increased by +5.19%
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 25 0.00
Decreased by N/A%
-84.71 M
Decreased by -46.24%
Decreased by N/A%
Decreased by N/A%
Mar 31, 25 7.50 M
Increased by +N/A%
-65.05 M
Decreased by -35.71%
Decreased by -867.29%
Decreased by N/A%
Dec 31, 24 2.52 M
Decreased by -53.23%
-65.69 M
Decreased by -46.81%
Decreased by -2.61 K%
Decreased by -213.92%
Sep 30, 24 0.00
Decreased by N/A%
-62.79 M
Decreased by -29.57%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-57.92 M
Decreased by -22.05%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-47.93 M
Decreased by -14.87%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 5.38 M
Increased by +61.27 K%
-44.74 M
Decreased by -19.65%
Decreased by -831.65%
Increased by +99.81%
Sep 30, 23 0.00
Decreased by -100.00%
-48.46 M
Decreased by -30.45%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY